Neuralink's First Human Trials: Breakthrough Paper Submitted to NEJM
Neuralink, Elon Musk's brain implant company, has submitted a scientific paper to the prestigious New England Journal of Medicine. The paper details the results from the first three patients implanted with the Neuralink device, marking a significant step in the company's quest to merge human brains with AI.
The paper, authored by researchers yet to be publicly disclosed, provides safety data from the initial human trials conducted at the Barrow Neurological Institute. Michael Lawton, CEO of the institute, confirmed the submission of the paper. The results from these first three patients are eagerly awaited by the scientific community and the public alike, as they will offer insights into the safety and potential of Neuralink's technology.
The submission of this paper to the New England Journal of Medicine signals that Neuralink's human trials are progressing as planned. While the authors and specific details remain under wraps, the world awaits the publication of this groundbreaking research.
Read also:
- Elon Musk accused by Sam Altman of exploiting X for personal gain
- China's Automotive Landscape: Toyota's Innovative Strategy in Self-Driving Vehicles
- L3Harris' RASOR Revolutionizes Military Communications with Secure Satellite Broadband
- EU Bolsters Defense Capabilities: Orbotix Secures €6.5M for AI-Driven Drones
